|
|
Approximately 25% of all reported medication errors result from some kind of name confusion.
Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.
As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.
More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.
People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.